Patents by Inventor CHRISTO KOLE

CHRISTO KOLE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transgenic RPE cells overexpressing OTX2 for the treatment of retinal degeneration
    Patent number: 11865189
    Abstract: The present invention relates to methods and composition for use in the treatment of retinal degeneration, in particular retinal degeneration due to retinal pigment epithelium dysfunction.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: January 9, 2024
    Assignees: SORBONNE UNIVERSITE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: Thierry Leveillard, Christo Kole, Jose-Alain Sahel
  • TRANSGENIC RPE CELLS OVEREXPRESSING OTX2 FOR THE TREATMENT OF RETINAL DEGENERATION
    Publication number: 20170348434
    Abstract: The present invention relates to methods and composition for use in the treatment of retinal degeneration, in particular retinal degeneration due to retinal pigment epithelium dysfunction.
    Type: Application
    Filed: December 17, 2015
    Publication date: December 7, 2017
    Applicants: UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6), CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
    Inventors: THIERRY LEVEILLARD, CHRISTO KOLE, JOSE-ALAIN SAHEL